Profil Financier
Leonard Schleifer occupe actuellement le rang #1541 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $2.7 B (+$226 sur 24h).
Leonard Schleifer cofounded drugmaker Regeneron in 1988, and remains CEO of the Tarrytown, New York-based company.
Schleifer took Regeneron public in 1991; he owns 2% of the company's common stock.
Sales of Regeneron's blockbuster drug Eylea, a treatment for macular degeneration, were $4.8 billion in the U.S. in 2024.
Regeneron has developed 12 FDA-approved medicines.
Schleifer attended Cornell on scholarship and dreamed of a medical career.
The son of a sweater manufacturer, Schleifer grew up in Queens, New York.